Systemic lupus erythematosus syndrome induced by practolol.

Cutaneous and ocular reactions to practolol. Br Med J (1974) 8.65

Untoward effects associated with practolol administration: oculomucocutaneous syndrome. Br Med J (1975) 3.33

Untoward effects associated with practolol: demonstration of antibody binding to epithelial tissue. Br Med J (1975) 3.12

Comparison of the effects of acebutolol (Sectral) and practolol (Eraldin) on airways obstruction in asthmatics. Br J Clin Pharmacol (1975) 1.90

Improvement in prognosis of myocardial infarction by long-term beta-adrenoreceptor blockade using practolol. A multicentre international study. Br Med J (1975) 1.76

Interstitial pulmonary fibrosis: a new side effect of practolol. Br Med J (1977) 1.74

Fibrinous peritonitis: a complication of practolol therapy. Br Med J (1975) 1.51

Beta-adrenergic receptor blocking drugs: tear lysozyme and immunological screening for adverse reaction. Br J Ophthalmol (1977) 1.49

The effect of beta-adrenoreceptive antagonists on the morbidity and mortality in cardiovascular disease. Postgrad Med J (1976) 1.46

Pathology of practolol-induced ocular toxicity. Br J Ophthalmol (1976) 1.39

Systemic lupus erythematosus syndrome induced by pindolol. Br Med J (1979) 1.32

Double-blind comparison of tolamolol, propranolol, practolol, and placebo in the treatment of angina pectoris. Br Med J (1975) 1.29

The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future. Br J Clin Pharmacol (1978) 1.11

Arthropathy induced by beta blockade. Br Med J (Clin Res Ed) (1984) 1.09

Antinative DNA antibodies as a reaction to pyrazole drugs. Ann Rheum Dis (1975) 1.03

Haemodynamic effects of atenolol in patients with coronary artery disease. Br Heart J (1978) 0.96

Drug-provoked psoriasis: is it drug induced or drug aggravated?: understanding pathophysiology and clinical relevance. J Clin Aesthet Dermatol (2010) 0.92

Hypotensive agents, beta-blockers, and drug-induced lupus. Br Med J (Clin Res Ed) (1982) 0.90

Antinuclear antibodies during procainamide treatment and drug acetylation. Br Med J (1975) 0.88

Practolol-induced autoantibodies and their relation to oculo-cutaneous complications. Postgrad Med J (1977) 0.87

Metabolites of procainamide and practolol inhibit complement components C3 and C4. Biochem J (1988) 0.81

Betaxolol and drug-induced lupus complicated by pericarditis and large pericardial effusion. West J Med (1997) 0.81

Practolol therapy associated with a systemic lupus erythematosus-like syndrome and an inhibitor to factor XIII. J Clin Pathol (1977) 0.81

Practolol-induced SLE-like syndrome. Proc R Soc Med (1976) 0.80

Practolol and the nephrotic syndrome. Br Med J (1975) 0.79

Psoriasis and psoriasiform eruptions associated with propranolol--the role of an immunological mechanism. Arch Dermatol Res (1991) 0.77

SLE syndrome, probably induced by labetalol. Postgrad Med J (1981) 0.77

Editorial: side effects of practolol. Br Med J (1975) 0.75

Abnormal lymphocyte function is secondary to drug-induced autoimmunity. Ann Rheum Dis (1976) 0.75

Ocular, systemic and antinuclear antibody changes with acebutolol. J R Coll Gen Pract (1983) 0.75

Importance of Publishing Adverse Drug Reaction Case Reports: Promoting Public Health and Advancing Pharmacology and Therapeutics. Drug Saf Case Rep (2017) 0.75

Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet (1971) 7.98

Significance of anti-D.N.A. antibodies in systemic lupus erythematosus. Lancet (1971) 6.22

Anti-DNA activity in systemic lupus erythematosus. A diagnostic and therapeutic guide. Ann Rheum Dis (1971) 3.76

Drug-induced lupus syndromes. Mayo Clin Proc (1969) 3.38

Lymphocyte blast transformation. I. Demonstration of adrenergic receptors in human peripheral lymphocytes. Cell Immunol (1970) 2.58

Alteration of the cytotoxic action of sensitized lymphocytes by cholinergic agents and activators of adenylate cyclase. Proc Natl Acad Sci U S A (1972) 2.01

Depression of immunological function in patients treated with phenytoin sodium (sodium diphenylhydantoin). Lancet (1971) 1.93

Quantified deficiency of lymphocyte response to phytohaemagglutinin in immune deficiency diseases. Clin Exp Immunol (1971) 1.89

Lupus-like syndrome induced by procainamide. Am J Cardiol (1967) 1.86

Procainamide-induced lupus erythematosus. N Engl J Med (1962) 1.80

Procainamide induction of a systemic lupus erythematosus-like syndrome. Presentation of six cases, review of the literature, and analysis and followup of reported cases. Medicine (Baltimore) (1969) 1.72

Detection of antibodies on blood lymphocytes in drug hypersensitivity using a rosette technique. Int Arch Allergy Appl Immunol (1971) 1.34

Natural antibodies to procaine amide. Clin Exp Immunol (1968) 1.31

FINDINGS SUGGESTIVE OF SYSTEMIC LUPUS ERYTHEMATOSUS IN SUBJECTS ON CHRONIC ANTICONVULSANT THERAPY. Arthritis Rheum (1965) 1.17

Systemic lupus erythematosus during treatment with procainamide. Br Heart J (1972) 1.17

Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet (1971) 7.98

Circadian variation of blood-pressure. Lancet (1978) 5.22

The lymphocyte transformation test and gold hypersensitivity. Ann Rheum Dis (1968) 3.54

Acute subvalvar mitral incompetence. Lancet (1966) 2.65

Failure of cytotoxic drugs to suppress immune responses of patients with rheumatoid arthritis. Ann Rheum Dis (1970) 2.42

First myocardial infarctions in Asian and white men. BMJ (1989) 2.40

Changes in the life-span of circulating small lymphocytes in mice after treatment with anti-lymphocyte globulin. Lancet (1968) 2.21

Verapamil in chronic stable angina. A controlled study with computerized multistage treadmill exercise. Lancet (1980) 2.05

Total body and serum potassium during prolonged thiazide therapy for essential hypertension. Lancet (1975) 2.01

Mode of action of anti-lymphocyte globulin. I. The distribution of rabbit anti-lymphocyte globulin injected into rats and mice. Immunology (1968) 1.98

Haemodynamic effects of long-term oral labetalol. Br J Clin Pharmacol (1976) 1.78

Effects of rate of infusion and probenecid on serum levels, renal excretion, and tolerance of intravenous doses of cefoxitin in humans: comparison with cephalothin. Antimicrob Agents Chemother (1974) 1.76

Combined therapy with verapamil and propranolol in chronic stable angina. Am J Cardiol (1982) 1.75

Ambulatory electrocardiographic records in patients with transient cerebral attacks or palpitation. Br Med J (1975) 1.71

Neurological complications in Behçet's syndrome. Brain (1999) 1.68

Incidence and management of supraventricular arrhythmias after acute myocardial infarction. Lancet (1967) 1.62

Relationship between plasma cholesterol and coronary artery disease in Asians. Atherosclerosis (1990) 1.61

Anticardiolipin antibodies: occurrence in Behçet's syndrome. Ann Rheum Dis (1984) 1.61

Suppression of Coombs-positive haemolytic anaemia in NZB mice by antilymphocyte globulin. Lancet (1967) 1.57

Chronic myelocytic leukemia. Origin of some lymphocytes from leukemic stem cells. J Clin Invest (1978) 1.55

The over-shoot phenomenon on withdrawal of clonidine therapy. Postgrad Med J (1976) 1.54

Infection of left ventricular thrombus in a patient with silent myocardial infarction--a unique complication. Eur Heart J (1993) 1.54

Anti-lymphocytic antibody and autoimmune disease: a review. Clin Exp Immunol (1969) 1.53

The effect of a new calcium channel blocker nicardipine on 24-hour ambulatory blood pressure and the pressor response to isometric and dynamic exercise. J Hypertens (1983) 1.53

Mode of action of anti-lymphocyte globulin. II. Changes in the lymphoid cell population in rats treated with anti-lymphocyte globulin. Immunology (1968) 1.49

Is the blood pressure the same in both arms? Clin Cardiol (1985) 1.47

Virus infections of lympho-reticular cells and auto-immune diseases. Transplant Rev (1976) 1.45

Depletion of long-lived lymphocytes in old New Zealand black mice. Clin Exp Immunol (1970) 1.44

The methodology of blood pressure recording. Br J Clin Pharmacol (1978) 1.42

Disturbances of insulin in British Asian and white men surviving myocardial infarction. BMJ (1989) 1.41

Baroreceptor, not left ventricular, dysfunction is the cause of hemodialysis hypotension. Clin Nephrol (1989) 1.40

Ambulatory ST segment monitoring. Problems, pitfalls, solutions, and clinical application. Br Heart J (1980) 1.39

Ventricular tachycardia induced by Valsalva's manoeuvre in a patient with hypertrophic cardiomyopathy. Int J Cardiol (1988) 1.39

Early diagnosis of acute myocardial infarction with use of a rapid immunochemical assay of creatine kinase MB isoenzyme. Clin Chem (1993) 1.38

Susceptibility of human lymphocyte populations to infection by herpes simplex virus. Immunology (1977) 1.37

A study of the antihypertensive action of xipamide using ambulatory intra-arterial monitoring. Br J Clin Pharmacol (1981) 1.35

Inactivation of myxoviruses by lymphoid cells. J Gen Virol (1973) 1.33

The Oxford continuous blood-pressure recorder--technical and clinical evaluation. Postgrad Med J (1976) 1.33

Tape monitoring of the electrocardiogram in ambulant patients with sinoatrial disease. Br Heart J (1973) 1.31

Transcutaneous aortovelography. A quantitative evaluation. Br Heart J (1976) 1.30

Control mechanisms in infectious mononucleosis. Clin Exp Immunol (1974) 1.29

Effect of anti-lymphocyte globulin on kidney disease in (N.Z.B. x N.Z.W.) F 1 mice. Lancet (1966) 1.27

Blood pressure and heart rate and withdrawal of antihypertensive drugs. Br Med J (1977) 1.27

The indirect method of recording blood pressure. Cardiovasc Res (1968) 1.25

Circadian variation of blood pressure in autonomic failure. Circulation (1983) 1.23

Effect of once-daily atenolol on ambulatory blood pressure. Br Med J (1979) 1.22

Lymphocyte abnormalities in Behçet's syndrome. Clin Exp Immunol (1980) 1.20

The Guillain-Barré syndrome following Campylobacter enteritis with recovery after plasmapheresis. J Infect (1983) 1.18

Use of graded exercise testing in assessing the hypertensive patient. Clin Cardiol (1980) 1.18

Once daily beta-adrenoceptor blockade in hypertension: an ambulatory assessment. Br J Clin Pharmacol (1981) 1.16

A new manifestation of infection with Epstein-Barr virus. Br Med J (1978) 1.14

Ventricular fibrillation threshold of healthy dogs to 50Hz current in relation to earth leakage currents of electromedical equipment. Biomed Eng (1972) 1.14

Defective B cell function in systemic lupus erythematosus. Clin Exp Immunol (1982) 1.13

Mechanisms of production of heart sounds based on records of sounds after valve replacement. Am J Cardiol (1966) 1.12

Left ventricular function during isometric hand grip and cold stress in normal subjects. Br Heart J (1986) 1.11

Thrombosis in Behçet's disease: a retrospective survey from a single UK centre. Rheumatology (Oxford) (2001) 1.11

Radionuclide left ventricular ejection fraction: a comparison of three methods. Br Heart J (1987) 1.10

Adoptive transfer of the diseases of New Zealand black mice to normal mouse strains. Clin Exp Immunol (1969) 1.08

Long-term antianginal action of verapamil assessed with quantitated serial treadmill stress testing. Am J Cardiol (1981) 1.08

Studies of the effect of induced immune lymphopenia. I. Enhanced effects of rabbit anti-rat lymphocyte globulin in rats tolerant to rabbit immunoglobulin G. J Immunol (1967) 1.08

Exercise-induced ST segment elevation. Electrocardiographic, angiographic, and scintigraphic evaluation. Br Heart J (1980) 1.08

Propranolol LA and ambulatory blood pressure. Br J Clin Pharmacol (1980) 1.07

Disturbances of heart rhythm produced by 50 Hz leakage currents in dogs. Cardiovasc Res (1975) 1.07

The infrasound blood-pressure recorder. A clinical evaluation. Lancet (1976) 1.07

Infection and interferon production in systemic juvenile chronic arthritis: a prospective study. Ann Rheum Dis (1984) 1.07

Radionuclide measurements of diastolic function for assessing early left ventricular abnormalities in the hypertensive patient. Br Heart J (1988) 1.06

Myocardial ischaemia in patients with frequent angina pectoris. Br Med J (1979) 1.05

Lymphokine-activated killer cell activity in rheumatoid arthritis. Clin Exp Immunol (1987) 1.05

Inactivation of influenza virus by human lymphocytes. Clin Exp Immunol (1974) 1.04

Herpes simplex virus depresses antibody production by affecting T-cell function. Nature (1980) 1.04

A controlled comparison of oxyfedrine, isosorbide dinitrate and placebo in the treatment of patients suffering attacks of angina pectoris. Br J Clin Pharmacol (1980) 1.03

Haemostatic variables and the outcome of myocardial infarction. Thromb Haemost (1983) 1.03

Once daily treatment of mild to moderate hypertension with xipamid: a controlled study. Br J Clin Pharmacol (1977) 1.03

Study of untreated hypertensive subjects by means of continuous intra-arterial blood pressure recordings. Br Heart J (1978) 1.03

Ambulant blood pressure: reproducibility and the assessment of interventions. Clin Sci (Lond) (1980) 1.03

Chlorambucil-induced chromosome damage to human lymphocytes is dose-dependent and cumulative. Lancet (1984) 1.02

Fate of herpes simplex virus in lymphocytes from inflammatory joint effusions. i. Failure of the virus to grow in cultured lymphocytes. Ann Rheum Dis (1979) 1.01

Interferon-gamma production by peripheral blood mononuclear cells from patients with Behçet's syndrome. Clin Exp Immunol (1984) 1.01

Radiosensitivity of peripheral blood lymphocytes in autoimmune disease. Int J Radiat Biol Relat Stud Phys Chem Med (1985) 1.01

Termination of acquired tolerance by administration of small lymphocytes. J Immunol (1967) 1.01

Clinical significance of the coronary arteriogram. Br Heart J (1971) 1.00

Mechanical performance of Hammersmith mitral valve prosthesis. Br Heart J (1968) 1.00

Replication or inactivation of different viruses by human lymphocyte preparations. Infect Immun (1974) 0.99

Patterns of blood-pressure during chronic administration of postganglionic sympathetic blocking drugs for hypertension. Lancet (1976) 0.99

Incidence and management of ventricular arrhythmias after acute myocardial infarction. Br Heart J (1969) 0.98

Nifedipine tablets for systemic hypertension: a study using continuous ambulatory intraarterial recording. Am J Cardiol (1983) 0.97

Intensive immunosuppression versus prednisolone in the treatment of connective tissue diseases. Ann Rheum Dis (1982) 0.97

Self-tolerance and autoimmunity. Br Med Bull (1976) 0.97

Cyclosporin A in the treatment of severe Behçet's uveitis. Br J Rheumatol (1987) 0.97

Streptokinase in acute myocardial infarction: a controlled multicentre study in the United Kingdom. Br Med J (1976) 0.96

Defective repair of 0(6)-methylguanine in autoimmune diseases. Lancet (1982) 0.96

The effects of metoprolol on ambulatory blood pressure. Clin Sci (Lond) (1979) 0.96

Detection of high risk coronary artery disease by thallium imaging. Br Heart J (1985) 0.95

Long-term recording of the electrocardiogram in a normal population. Postgrad Med J (1976) 0.95

The 24-hour ambulatory blood pressure profile with verapamil. Circulation (1982) 0.95

Immunodeficiency and general medicine. Br Med J (1980) 0.95

Nifedipine tablets for hypertension: a study using continuous ambulatory intra-arterial recording. Postgrad Med J (1983) 0.95

Pregnancy and immunological disorders. Br Med J (Clin Res Ed) (1982) 0.94

Does placebo lower blood-pressure? Lancet (1982) 0.94

Assessment of left ventricular function in coronary artery disease with the nuclear probe during intervention studies. Br Heart J (1984) 0.94